Calyxt (CLXT) Receives EU Patent on Use of CRISPR/Cas9 for Genome Editing in Plants

December 17, 2018 4:32 PM EST Send to a Friend
Calyxt, Inc. (NASDAQ: CLXT), a consumer-centric, food- and agriculture-focused company, today announced the issuance of European patent No. 3008186, which ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login